NuVasive has reached a definitive settlement with the US Department of Justice (DOJ) related to the subpoena issued to the company by the Office of Inspector General of the Department of Health and Human Services in 2013. NuVasive admits no wrongdoing as part of the settlement.
Having settled the investigation, the company has now entered into a definitive settlement agreement with the USA, acting through DOJ and on behalf of the Office of Inspector General, the Defense Health Agency, the Office of Personnel Management, and the US Department of Veteran Affairs.
Under the terms of the settlement agreement, the company will pay US$13.5m, plus fees and accrued interest. The settlement is neither an admission of liability or wrongdoing by the company nor a concession by the USA that its claims are not well founded.
Recognising the government’s responsibility to ensure the appropriateness of industry practices, the company stated that it cooperated fully with the inquiry and “has continued to work hard to create and sustain a culture of compliance throughout its operations”. Resolution of the matter avoids the time and expense of a potentially lengthy litigation process. The company was not required to enter into a corporate integrity agreement by the Office of Inspector General as part of the settlement.